- Telehealth Visits
David Hoskins, PsyD
Psychology (Child and Adolescent Psychology)- Telehealth Visits
David Hoskins, PsyD
Psychology (Child and Adolescent Psychology)- Telehealth Visits
On this page
About me
David Hoskins is a psychologist who cares for individuals, families and groups. He specializes in trauma-focused therapy, family systems theory and pediatric psychology.
Hoskins' research focuses on examining unmet behavioral health needs – including psychiatric symptoms, substance use and sexual risk behaviors – in the primary care setting and within the juvenile justice system. He is also interested in supporting the Latinx community and in providing culturally attuned mental health services for youths who have experienced interpersonal trauma.
Hoskins earned his doctor of psychology degree from the California School of Professional Psychology at Alliant International University. He completed a master of advanced study degree in clinical research at UCSF. He has been a participant in the American Psychological Association's Minority Fellowship Program.
Hoskins has received numerous honors, including awards from the National Institutes of Health, National Institute on Drug Abuse and National Institute on Minority Health Disparities.
Education
Fellowship
- Clinical Research, UCSF School of Medicine -GME
Residency
- Pediatrics and Trauma-Informed Care, UCSF School of Medicine -GME
School
- PSYD, California School of Professional Psychology
Academic Title
- Clinical Professor
Care Keywords
Services
- Psychology (Child and Adolescent Psychology)
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.